Surgery Partners (SGRY) Cash from Investing Activities (2014 - 2026)

Surgery Partners' Cash from Investing Activities history runs 13 years deep, the most recent figure standing at -$13.4 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 82.46% year-over-year to -$13.4 million; the TTM figure through Mar 2026 stood at -$183.6 million (up 61.89% YoY), while the FY2025 annual figure was -$246.6 million, up 49.52% from the prior year.
• Cash from Investing Activities came in at -$13.4 million for Q1 2026 at Surgery Partners, up from -$126.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $2.1 million in Q2 2025 to a low of -$244.1 million in Q2 2024.
• A 5-year average of -$75.4 million and a median of -$70.7 million in 2023 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities tumbled 408.71% in 2022 and surged 100.86% in 2025, its largest moves.
• Surgery Partners' Cash from Investing Activities stood at -$72.2 million in 2022, then advanced by 19.53% to -$58.1 million in 2023, then plunged by 92.25% to -$111.7 million in 2024, then declined by 12.89% to -$126.1 million in 2025, then surged by 89.37% to -$13.4 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$13.4 million, -$126.1 million, and -$46.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison